Is Eastman Chemical (EMN) Stock Trading At A Discount To Fair Value?
Eastman Chemical stock has delivered a decline of 24.5% over the past five years, while current valuation checks suggest the shares may now trade below an estimate of intrinsic value based on discounted cash flows and earnings multiples.
- The share price has fallen 24.5% over five years, which may indicate that sentiment has been weaker than the company’s long term cash generating potential.
- Future cash flow growth and margin stability can support the current valuation, while any sustained pressure on volumes or input costs may limit how much of that cash flow turns into value for shareholders.
- The broader checks lean cheap, with a high value score of 5 out of 6. This suggests Eastman Chemical screens as undervalued on most measures.
The issue now is whether Eastman Chemical’s current share price already reflects its cash flow potential or if the intrinsic value estimate points to a wider margin between price and value.
Spot potential peers to Eastman Chemical by scanning 50 high quality undervalued stocks, which also combine compressed share prices with stronger value checks.Is Eastman Chemical a Bargain on Cash Flow?
The Discounted Cash Flow model for Eastman Chemical projects how much free cash the company could return to shareholders over time. In this view, Eastman Chemical is modeled with recovering free cash flow, from the latest twelve month figure of about $418 million up toward higher annual levels over the next decade, which is consistent with a mature chemicals business rather than a hyper growth profile.
Those cash flow projections feed into an estimated intrinsic value of about $127 per share, which sits above the current share price. The implied 44.8% discount indicates that the market price may not fully reflect the projected cash generation that this DCF model assumes for Eastman Chemical.
On these DCF assumptions, Eastman Chemical stock appears undervalued relative to the implied intrinsic value per share.
Our Discounted Cash Flow (DCF) analysis suggests Eastman Chemical is undervalued by 44.8%. Track this in your watchlist or portfolio, or discover 50 more high quality undervalued stocks.
Is Eastman Chemical a Bargain on Earnings?
For a mature chemicals business like Eastman Chemical, the P/E ratio is a straightforward way to see how the market prices each dollar of earnings. Eastman Chemical currently trades on a P/E of about 18.1x. That sits below the broader Chemicals industry average of around 23.8x and also below the peer group average near 33.6x. On simple comparisons, investors are paying a lower multiple for Eastman Chemical’s earnings than for many sector peers.
A more tailored fair P/E for Eastman Chemical, which blends its industry, profitability profile, size and risk factors, is estimated at about 21.1x. The current 18.1x level is below this reference point. This indicates that the stock trades at a discount to what this framework would suggest for its earnings profile.
On the P/E multiple, Eastman Chemical stock appears undervalued relative to both its industry and a more tailored fair value benchmark.
See what the numbers say about this price — find out in our valuation breakdown.
The Eastman Chemical Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where the Eastman Chemical valuation puzzle leaves off. They spell out what assumptions on Eastman Chemical's growth, margins and earnings would need to hold for the stock to be worth materially more or less than today's price. Each narrative links a fair value estimate to a clear story about the company's potential catalysts and risks so you can track which version seems to be playing out over time.
One of the top community narratives on Eastman Chemical: 5% undervalued
"Large scale, recurring capital expenditures required for plant modernization, regulatory compliance, and sustainability projects are likely to suppress free cash flow..."
Read one of the top narratives on Eastman Chemical
Do you think there's more to the story for Eastman Chemical? Head over to our Community to see what others are saying!
The Bottom Line
Eastman Chemical screens as undervalued on both the Discounted Cash Flow (DCF) intrinsic value estimate and the earnings multiple view, which broadly point in the same direction. The common thread is whether the company can sustain cash generation and margins at the levels implied by those models. If that holds and sentiment toward the sector improves, the current discount may gradually narrow. If cash flows remain pressured by volumes or input costs, the present gap between price and intrinsic value could prove to be a value trap rather than an opportunity.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com